Filter
718
Filtered Results: 718
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
65
New Publications
181
Language
Document type
No document type
294
Studies & Reports
190
Guidelines
111
Manuals
59
Strategic & Response Plan
40
Training Material
9
Fact sheets
9
Situation Updates
5
Resource Platforms
1
Countries / Regions
Global
39
Kenya
30
Nigeria
17
India
17
South Africa
14
Uganda
14
Ethiopia
14
Ghana
13
Western and Central Europe
12
Liberia
12
Sierra Leone
11
Rwanda
10
Latin America and the Carribbean
10
Zimbabwe
9
Philippines
9
Tanzania
9
Nepal
8
Ukraine
8
Zambia
8
Eastern Europe and Central Asia
7
Bangladesh
7
Malawi
6
Africa
6
Namibia
6
Myanmar / Burma
6
Syria
5
West and Central Africa
5
South–East Asia Region
5
East and Southern Africa
5
Thailand
4
Cambodia
4
Botswana
4
Benin
3
Laos
3
Senegal
3
Asia
3
Middle East and North Africa
3
Indonesia
3
Eswatini/ Swaziland
3
North Macedonia
2
Tajikistan
2
Cameroon
2
Burkina Faso
2
Mozambique
2
Congo, Democratic Republic of
2
Western Pacific Region
2
North America
2
United Kingdom
2
Eastern Europe
2
Timor Leste/ East Timor
1
Serbia
1
Lesotho
1
Kazakhstan
1
Iran
1
Albania
1
Kyrgyzstan
1
Uzbekistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Armenia
1
Haiti
1
Venezuela
1
Gabon
1
Vietnam
1
Brazil
1
Moldova
1
Russia
1
Sudan
1
Georgia
1
Mali
1
Angola
1
South Sudan
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
267
Clinical Guidelines
67
Public Health
49
Key Resources
27
Pharmacy & Technologies
25
Women & Child Health
20
Capacity Building
5
Toolboxes
AMR
83
Pharmacy
70
COVID-19
47
Mental Health
30
NTDs
30
HIV
28
TB
27
Planetary Health
23
Rapid Response
22
Health Financing Toolbox
19
Caregiver
18
Global Health Education
17
Conflict
15
NCDs
13
Malaria
12
Ebola & Marburg
9
Specific Hazards
5
Refugee
3
Disability
3
2.0 Rapid Response
2
Polio
2
Natural Hazards
1
Social Ethics
1
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
English Analysis on World about Climate Change and Environment, Health and Epidemic; published on 03 Nov 2021 by World Bank
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
A new publication - Waste Management during the COVID-19 Pandemic: from response to recovery - reviews current practices for managing waste from healthcare facilities, households and quarantine locations accommodating people with confirmed or suspected cases of COVID-19. Jointly produced by UNEP, th...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
The relative priority received by issues
in global health agendas is subjected to impressionistic
claims in the absence of objective methods of assessment
of priority. To build an approach for conducting structured
assessments of comparative priority health issues receive,
we expand the public ...
PLOS Neglected Tropical Diseases 18(4): e0012111. https://doi.org/10.1371/journal.pntd.0012111
Interim Version 24, February 2020
This checklist has been prepared with the aim of supporting hospital managers and emergency planners in achieving the above by defining and initiating actions needed to ensure a rapid response to the COVID-19 outbreak. The checklist is structured on eleven key co...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
PlosOne May 7, 2012 https://doi.org/10.1371/journal.pone.0036735 ; Safe drinking water is critical for health. Household water treatment (HWT) has been recommended for improving access to potable water where existing sources are unsafe. Reports of low adherence to HWT may limit the usefulness of thi...
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
It summarizes guidance on how to manage – and when to refer – children and adolescents presenting with common complaints and conditions. It includes information to enable primary health care providers to coordinate the continued care of children and adolescents with long-term conditions and dise...
Introduction
Chapter A.6
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
